New Cancer Treatment Method More Effective and Less Painful

Cancer patients may soon experience more effective treatment with fewer needles and less discomfort, thanks to a discovery by Australian researchers.

Scientists at Monash University found that combining cancer immunotherapy with an enzyme called hyaluronidase allows the medicine to be injected under the skin instead of through an IV. The real surprise? This simpler method actually works better for certain treatments.

Traditional cancer immunotherapy requires patients to sit for hours receiving high doses through intravenous drips. The new approach takes just minutes with a simple injection under the skin, similar to a vaccine shot.

The key is hyaluronidase, an enzyme that temporarily breaks down a substance in the tissue beneath our skin. This creates space for larger volumes of medicine to be absorbed. Researchers partnered with Halozyme Therapeutics, the company that developed this specialized enzyme.

Professor Chris Porter and Dr. Orlagh Feeney, who led the study, explained that hyaluronidase does more than just make injections easier. For the first time, they proved it actually boosts how well the treatment works.

The secret lies in how the medicine travels through the body. Subcutaneous injections help immunotherapy reach the lymphatic system, where immune responses are generated and strengthened. Since many cancers involve lymph nodes, delivering treatment directly to this system creates a more powerful effect.

Dr. Gracia Gracia from Monash Institute of Pharmaceutical Sciences noted that this approach is particularly promising for cancers affecting tumor-draining lymph nodes. The treatment goes exactly where it needs to fight the disease.

The research, published in Cancer Immunology Research, addresses a major challenge in cancer care. Many patients struggle with the time commitment and physical toll of IV treatments. Some avoid treatment altogether because of the difficulty.

Why This Inspires

This breakthrough shows that better doesn't always mean more complicated. By simplifying how medicine is delivered, researchers made it both easier on patients and more effective at fighting cancer.

The FDA has already begun approving subcutaneous versions of several cancer drugs, showing this approach is moving from lab to real-world care. Millions of cancer patients could benefit from shorter, more comfortable treatment sessions that work even better than current methods.

One injection could replace hours of IV treatment while improving outcomes.